SUBSCRIBE
SUBSCRIBE

BioMidwest

Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, Ohio & Wisconsin

BioMidwest is home to manufacturing facilities, biotech, pharma and medical device companies—and BioSpace!—making the heartland a thriving hub for industry.

Major universities in the area, including the University of Chicago and Northwestern University, contribute to the industry’s success to create powerful pipelines of talent in this region.

BioMidwest is also home to state membership associations including iBIO, Indiana Health Industry Forum, IowaBio, MichBio, Missouri Biotechnology Association, Bio Nebraska, Ohio Life Sciences and BioForward Wisconsin.

FEATURED COMPANIES
NEWS FROM BIOMIDWEST
Courtesy of Abbvie Inc.
Drug Development
AbbVie’s Skyrizi Becomes First FDA-Approved IL-23 Inhibitor for Crohn’s Disease
June 20, 2022
 · 
2 min read
 · 
Vanessa Doctor, RN
Courtesy of Cristina Arias/Getty Images
Drug Development
Eli Lilly’s Olumiant Becomes First Systemic Treatment for Alopecia Areata
June 14, 2022
 · 
2 min read
 · 
Vanessa Doctor, RN
Drug Development
AbbVie, Biohaven, Teva and Satsuma Tackle Migraine at AHS
June 9, 2022
 · 
4 min read
 · 
Mark Terry
Susan Montgomery/Shutterstock
Drug Development
Eli Lilly’s Phase III Atopic Dermatitis Drug Touts Significant Skin Clearance
June 7, 2022
 · 
2 min read
 · 
Vanessa Doctor, RN
Load More
See the latest job opportunities in BioMidwest
SEARCH JOBS
Jonathan Weiss/Shutterstock
Business
Eli Lilly and Foghorn to Leverage Gene Traffic Control in Oncology
The collaboration covers the co-development and co-commercialization of products created from Foghorn’s BRM oncology program and another oncology target.
December 13, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
Drug Development
Clinical Catch-Up: December 6-10
December 10, 2021
 · 
14 min read
 · 
Mark Terry
Courtesy of Getty Photos
Business
Eli Lilly Focuses on Obesity and Diabetes with $1.5 Billion Deal
December 10, 2021
 · 
2 min read
 · 
Alex Keown
BioMidwest
Lilly & Boehringer’s Diabetes Drug Slashes Hospitalization Risk for HF by 50%
June 6, 2022
 · 
3 min read
 · 
Mark Terry
Business
Athersys Culls 70% of Staff in Effort to Prioritize MultiStem Programs
June 3, 2022
 · 
2 min read
 · 
Alex Keown
Courtesy of justhavealook/Getty Images
Job Trends
Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies
June 2, 2022
 · 
3 min read
 · 
Alex Keown
Drug Development
Takeda, Seagen and Y-mAbs Highlight Data in Difficult Cancers Ahead of ASCO
May 27, 2022
 · 
3 min read
 · 
Vanessa Doctor, RN
Load More
MORE COMPANIES IN BIOMIDWEST
Battelle
Cingulate Therapeutics
CMIC Inc
DiaMedica Therapeutics, Inc.
Elephas
Humanetics
ImmunoPhotonics
INCOG BioPharma Services
Medexus Pharma
Northstar Medical Radiosotopes
Odyssey Therapeutics
ONL Therapeutics
Perspective Therapeutics
Sudo Biosciences
TE Connectivity
Telix Pharmaceuticals
TerSera Therapeutics
Drug Development
Athersys Shares Pummeled as Ischemic Stroke Study Misses Endpoint
May 20, 2022
 · 
2 min read
 · 
Vanessa Doctor, RN
BioMidwest
Deadly Venom is Being Turned into Life-Saving Medical Treatments
May 17, 2022
 · 
4 min read
 · 
Mark Terry
Business
AbbVie, AstraZeneca See Value in what Cugene, Proteros Have to Offer
May 16, 2022
 · 
3 min read
 · 
Mark Terry
Courtesy photobyphm/Getty Images
Business
Teva Holds off Huntington’s Competitor, Resolves Opioid Cases
May 3, 2022
 · 
3 min read
 · 
Mark Terry
Load More
Interested in appearing on the Hotbed Maps?
Find out how your organization can be featured!
LEARN MORE